REFERENCES
- Chanson P, Salenave S. Diagnosis and treatment of pituitary adenomas. Minerva Endocrinol 2004; 29(4) 241–275.
- Trouillas J. Pathology and pathogenesis of pituitary corticotroph adenoma. Neu-rochirurgie 2002; 48(2–3 Pt 2): 149–162.
- Chang CY, Luo CB, Teng MM, Guo WY, Chen SS, Lirng JF, Chang FC, Formos J. Computed tomography and magnetic resonance imaging charcteristics of giant pituitary adenomas. J Formos Med Assoc 2000; 99(11): 833–838.
- Minniti G,Jaffrain-Rea ML, Santoro A, Esposito V, Ferrante L, Delfini R, Cantore G. Giant prolactinomas presenting as skull base tumors. Surg Neurol 2002; 57(2): 99–103.
- Hashimoto K, Nagano I, Asaba K, Inoue M, Nishioka T, Takao T, Nakajo T, Mon T, Kurisaka M, Otsuka F. Significant gene expression of insulin-like growth factor II and proliferating cell nuclear antigen in a rapidly growing recurrent pituitary acth-secreting adenoma. Harm Res 2000; 54(4): 198–202.
- Arbolay OL, Gonzalez JG, Gonzalez RH, Galvez YH. Extended endoscopic endo-nasal approach to the skull base. Minim Invasive Neurosurg 2009; 52(3): 114–118, Epub 2009 jul 31.
- Verrees M, Arafah BM, Selman WR. Pituitary tumor apoplexy: characteristics, treatment, and outcomes. Neurosurg Focus 2004; 16.
- Barzaghi LR, Losa M, Giovanelli M, Mortini P. Complications of transsphenoidal surgery in patients with pituitary adenoma: Experience at a Single Centre. Acta Neurochir (Wien) 2007; 149(9): 877–885.
- Lu YJ, Chang CN, Pai PC, Wei KC, Chuang CC. Isolated sphenoid sinusitis or mucocele: a potential complication of endonasal transsphenoidal surgery. J Neu-rooncol 2009; 91:63–67.